Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shoji Mitsufuji is active.

Publication


Featured researches published by Shoji Mitsufuji.


Helicobacter | 2003

Antimicrobial Activity of Essential Oils against Helicobacter pylori

Tomoyuki Ohno; Masakazu Kita; Yoshio Yamaoka; Shigeyoshi Imamura; Toshiro Yamamoto; Shoji Mitsufuji; Tadashi Kodama; Kei Kashima; Jiro Imanishi

Background. Helicobacter pylori is an important pathogen responsible for gastroduodenal diseases in humans. Although the eradication of H. pylori using antibiotics often improves gastroduodenal diseases, resistance to the antibiotics is emerging.


Digestive Diseases and Sciences | 2003

Expression of Musashi-1 in Human Normal Colon Crypt Cells A Possible Stem Cell Marker of Human Colon Epithelium

Satoshi Nishimura; Naoki Wakabayashi; Kazuyuki Toyoda; Kei Kashima; Shoji Mitsufuji

Musashi has been identified as an RNA-binding protein thought to be involved in asymmetric divisions during Drosophila neural development. To analyze expression patterns of mammalian Musashi homolog Musashi-1 in human normal colon crypt, 155 colon crypts separated from biopsy specimens of normal colonic mucosa were evaluated. Specimens were fixed, microdissected to isolate a few crypts, immunostained with anti-Musashi-1 antibody (14H1), and examined under confocal laser scan microscopy. The number of Musashi-1-positive cells in each crypt was 19.0 ± 7.53 (mean ± SD). Most Musashi-1 positive cells were located at the crypt base, between cell positions 1 and 10. Distribution of Musashi-1-positive cells corresponded with that of stem cells, as outlined in previous reports, implying that Musashi-1 is a key control element of asymmetrical division within the colon crypt. This is the first report outlining expression of Musashi-1 in human colon crypt cells.


British Journal of Cancer | 2004

Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation

Fukuda K; Chouhei Sakakura; Miyagawa K; Y Kuriu; Shuichi Kin; Nakase Y; Akeo Hagiwara; Shoji Mitsufuji; Yasushi Okazaki; Yoshihide Hayashizaki; Hisakazu Yamagishi

Radiation therapy is a powerful tool for the treatment of oesophageal cancer. We established radioresistant cell lines by applying fractionated irradiation in order to identify differentially expressed genes between parent and radioresistant cells. Six oesophageal cancer cell lines (TE-2, TE-5, TE-9, TE-13, KYSE170, and KYSE180) were treated with continuous 2 Gy fractionated irradiation (total dose 60 Gy). We compared expression profiles of each parent and radioresistant lines on a cDNA microarray consisting of 21168 genes. In the fractionated irradiation trial, four radioresistant sublines (TE-2R, TE-9R, TE-13R, KYSE170R) were established successfully, and we identified 19 upregulated and 28 downregulated genes common to radioresistant sublines. Upregulated genes were associated with apotosis and inflammatory response (BIRC2 and COX-2), DNA metabolism (CD73), and cell growth (PLAU). Downregulated genes were associated with apoptosis (CASP6), cell adhesion (CDH1 and CDH3), transcription (MLL3), and cell cycle (CDK6). Some of these genes were known to be associated with radiation response, such as COX-2, but others were novel. Reverse transcription–polymerase chain reaction confirmed that genes selected by cDNA microarray were overexpressed in clinical specimens of radioresistant cases. Global gene analysis of radioresistant sublines may provide new insight into mechanisms of radioresistance and effective radiation therapy.


Infection and Immunity | 2000

Cytokine Expression and Production by Purified Helicobacter pylori Urease in Human Gastric Epithelial Cells

Toshihito Tanahashi; Masakazu Kita; Tadashi Kodama; Yoshio Yamaoka; Naoki Sawai; Tomoyuki Ohno; Shoji Mitsufuji; Ya-Ping Wei; Kei Kashima; Jiro Imanishi

ABSTRACT Cytokines have been proposed to play an important role inHelicobacter pylori-associated gastroduodenal diseases, but the exact mechanism of the cytokine induction remains unclear. H. pylori urease, a major component of the soluble proteins extracted from bacterial cells, is considered to be one of the virulence factors for the inflammation in the gastric mucosa that is produced in H. pylori infection. However, the response of human gastric epithelial cells to the stimulation of urease has not been investigated. In the present study, we used human gastric epithelial cells in a primary culture system and examined whetherH. pylori urease stimulates the gastric epithelial cells to induce proinflammatory cytokines by reverse transcription-PCR and enzyme-linked immunosorbent assay. First, by using peripheral blood mononuclear cells (PBMC) and a gastric cancer cell line (MKN-45 cells), we confirmed the ability of purified H. pylori urease to induce the production of proinflammatory cytokines. Furthermore, we demonstrated that the human gastric epithelial cells produced interleukin-6 (IL-6) and tumor necrosis factor alpha, but not IL-8, following stimulation with purified urease. The patterns of cytokine induction differed among human PBMC, MKN-45 cells, and human gastric epithelial cells. These results suggest that the human gastric epithelial cells contribute to the induction of proinflammatory cytokines by the stimulation of H. pylori urease, indicating that the epithelial cells were involved in the mucosal inflammation that accompanied H. pylori infection.


Helicobacter | 2008

IL-17 is Involved in Helicobacter pylori-Induced Gastric Inflammatory Responses in a Mouse Model

Satoshi Shiomi; Akihiro Toriie; Shigeyoshi Imamura; Hideyuki Konishi; Shoji Mitsufuji; Yoichiro Iwakura; Yoshio Yamaoka; Hiroyoshi Ota; Toshiro Yamamoto; Jiro Imanishi; Masakazu Kita

Background:  Helicobacter pylori (H. pylori) is the major cause of chronic active gastritis and peptic ulcer disease. Recent studies have shown that H. pylori produces various cytokines that are related to neutrophil or mononuclear cell accumulation. Interleukin‐17 (IL‐17) is the founding member of an emerging family of inflammatory cytokines whose biological activities remain incompletely defined. In this study, the contributions of IL‐17 to the induction of gastric inflammation and to the protection from H. pylori infection were investigated using IL‐17 gene‐knockout (IL‐17−/–) mice.


Oncogene | 2009

Defective expression of polarity protein PAR-3 gene ( PARD3 ) in esophageal squamous cell carcinoma

Keika Zen; Kohichiroh Yasui; Yasuyuki Gen; Osamu Dohi; Naoki Wakabayashi; Shoji Mitsufuji; Yoshito Itoh; Yoh Zen; Yasuni Nakanuma; Masafumi Taniwaki; Takeshi Okanoue; Toshikazu Yoshikawa

The partition-defective 3 (PAR-3) protein is implicated in the formation of tight junctions at epithelial cell–cell contacts. We investigated DNA copy number aberrations in human esophageal squamous cell carcinoma (ESCC) cell lines using a high-density oligonucleotide microarray and found a homozygous deletion of PARD3 (the gene encoding PAR-3). Exogenous expression of PARD3 in ESCC cells lacking this gene enhanced the recruitment of zonula occludens 1 (ZO-1), a marker of tight junctions, to sites of cell–cell contact. Conversely, knockdown of PARD3 in ESCC cells expressing this gene caused a disruption of ZO-1 localization at cell–cell borders. A copy number loss of PARD3 was observed in 15% of primary ESCC cells. Expression of PARD3 was significantly reduced in primary ESCC tumors compared with their nontumorous counterparts, and this reduced expression was associated with positive lymph node metastasis and poor differentiation. Our results suggest that deletion and reduced expression of PARD3 may be a novel mechanism that drives the progression of ESCC.


Oncogene | 2005

ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation

Hisashi Takada; Issei Imoto; Hitoshi Tsuda; Yukihiro Nakanishi; Takashi Ichikura; Hidetaka Mochizuki; Shoji Mitsufuji; Fumie Hosoda; Setsuo Hirohashi; Misao Ohki; Johji Inazawa

Array-based comparative genomic hybridization (CGH-array) has a powerful potential for high-throughput identification of genetic aberrations in cell genomes. We identified a homozygous loss of ADAM23 (2q33.3) in the course of a program to screen a panel of gastric cancer (GC) cell lines (1/32, 3.1%) for genomic copy-number aberrations using our custom-made CGH-array. Infrequent homozygous deletion of ADAM23 was also seen in primary gastric tumors (1/39, 2.6%). ADAM23 mRNA was expressed in normal stomach tissue, but not in the majority of GC cell lines without homozygous deletion of this gene. Expression of ADAM23 mRNA was restored to gene-silenced GC cells after treatment with 5-aza 2′-deoxycytidine. The methylation status of the ADAM23 CpG island, which showed promoter activity, correlated inversely with its expression. Methylation of this CpG island was observed both in GC cell lines and in primary GC tissues; in primary tumors with a hypermethylated CpG island, expression of ADAM23 was lower than in adjacent noncancerous tissues. Moreover, restoration of ADAM23 in GC cells reduced their numbers in colony-formation assays. These results suggest that genetic or epigenetic silencing by hypermethylation of the ADAM23 CpG-rich promoter region leads to loss of ADAM23 function, which may be a factor in gastric carcinogenesis.


Journal of Gastroenterology and Hepatology | 2009

Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres

Akiko Danjo; Kanako Yamaguchi; Kazuma Fujimoto; Toshihito Saitoh; Masahiko Inamori; Takashi Ando; Tomohiko Shimatani; Kyoichi Adachi; Fukunori Kinjo; Shiko Kuribayashi; Shoji Mitsufuji; Yasuhiro Fujiwara; Shigeki Koyama; Junichi Akiyama; Atsushi Takagi; Noriaki Manabe; Hiroto Miwa; Yasuyuki Shimoyama; Motoyasu Kusano

Background and Aim:  We compared endoscopic findings of the frequency scale for the symptoms of gastroesophageal reflux disease (FSSG), a written questionnaire developed in Japan, to that for the questionnaire for the diagnosis of reflux esophagitis (QUEST) for the diagnosis of reflux esophagitis.


Genes, Chromosomes and Cancer | 2009

ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry

Keika Zen; Kohichiroh Yasui; Tomoaki Nakajima; Yoh Zen; Kan Zen; Yasuyuki Gen; Hironori Mitsuyoshi; Masahito Minami; Shoji Mitsufuji; Shinji Tanaka; Yoshito Itoh; Yasuni Nakanuma; Masafumi Taniwaki; Shigeki Arii; Takeshi Okanoue; Toshikazu Yoshikawa

Using high‐density oligonucleotide microarrays, we investigated DNA copy‐number aberrations in cell lines derived from hepatocellular carcinomas (HCCs) and detected a novel amplification at 17p11. To identify the target of amplification at 17p11, we defined the extent of the amplicon and examined HCC cell lines for expression of all seven genes in the 750‐kb commonly amplified region. Mitogen‐activated protein kinase (MAPK) 7, which encodes extracellular‐regulated protein kinase (ERK) 5, was overexpressed in cell lines in which the gene was amplified. An increase in MAPK7 copy number was detected in 35 of 66 primary HCC tumors. Downregulation of MAPK7 by small interfering RNA suppressed the growth of SNU449 cells, the HCC cell line with the greatest amplification and overexpression of MAPK7. ERK5, phosphorylated during the G2/M phases of the cell cycle, regulated entry into mitosis in SNU449 cells. In conclusion, our results suggest that MAPK7 is likely the target of 17p11 amplification and that the ERK5 protein product of MAPK7 promotes the growth of HCC cells by regulating mitotic entry.


Gastrointestinal Endoscopy | 2000

Endoscopic mucosal resection using a partial transparent hood for lesions located tangentially to the endoscope

Masao Noda; Noriaki Kobayashi; Hidetoshi Kanemasa; Toshihito Tanahashi; Naoki Wakabayashi; Shoji Mitsufuji; Tadashi Kodama; Kei Kashima

BACKGROUND Numerous methods have been developed to resect early-stage gastric and esophageal cancers, but it is difficult to resect lesions viewed tangentially with the endoscope. METHODS We have designed and developed an original method of endoscopic mucosal resection using a partial transparent hood to treat difficult cases in which the lesions are located tangentially to the endoscope. The hood was attached on the right side of the endoscope and, after insertion into the stomach or the esophagus, was lightly pressed on the orad side of the lesion. Then the lesion was resected using grasping forceps and electrosurgical current snare. RESULTS The average diameter of specimens was 26 +/- 8 mm in gastric lesions and 20 +/- 3 mm in esophageal lesions, both 6 mm larger than those obtained by previous methods. CONCLUSION This device and technique were extremely useful for mucosal resection of lesions located tangentially to the endoscope.

Collaboration


Dive into the Shoji Mitsufuji's collaboration.

Top Co-Authors

Avatar

Tadashi Kodama

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Takeshi Okanoue

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Naoki Wakabayashi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kei Kashima

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hideyuki Konishi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Keisho Kataoka

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kazuhiko Tokita

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Masafumi Taniwaki

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hideharu Tsuji

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hitoshi Okano

Kyoto Prefectural University of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge